Valuation: Harbin Gloria Pharmaceuticals Co., Ltd

Market Cap 6.36B 941M 818M 761M 699M 1.32B 89.81B 1.34B 8.97B 3.52B 44.71B 3.53B 3.46B 150B P/E 2024
24.2x
P/E 2025 18.2x
Enterprise Value 5.52B 817M 710M 661M 607M 1.15B 77.97B 1.16B 7.79B 3.06B 38.82B 3.07B 3B 130B EV / Sales 2024
2.12x
EV / Sales 2025 2.82x
Free-Float
90.63%
Yield 2024 *
-
Yield 2025 -
1 day+0.35%
1 week+3.26%
1 month+5.56%
3 months-19.03%
6 months-16.42%
Current year-7.17%
1 week 2.72
Extreme 2.72
2.97
1 month 2.72
Extreme 2.72
3.24
Current year 2.37
Extreme 2.37
3.99
1 year 2.37
Extreme 2.37
4
3 years 1.66
Extreme 1.66
4.08
5 years 1.66
Extreme 1.66
4.08
10 years 1.66
Extreme 1.66
9.8
Manager TitleAgeSince
Chief Executive Officer 53 25/12/2022
Corporate Officer/Principal 42 17/04/2018
Corporate Officer/Principal 40 22/05/2019
Director TitleAgeSince
Director/Board Member 40 13/03/2025
Director/Board Member 53 10/11/2022
Director/Board Member 42 10/11/2022
Date Insider Type Main position Quantity % Market Cap.
02/07/25 Sell 587,500 0.0283%
02/07/25 Sell

Director

259,600 0.0125%
02/07/25 Sell 587,500 0.0283%
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%+3.26%-23.18%+27.80% 941M
-0.53%+2.54%+16.63%+74.09% 50.03B
-1.81%-0.49%+51.99%+112.44% 36.6B
+0.46%+4.44%-5.24%+25.38% 12.47B
+1.05%+1.63%+16.19%+78.22% 11.77B
-1.33%-0.76%+30.08%+131.70% 9.04B
-2.99%-2.09%+41.02%-8.36% 7.03B
+0.51%+1.46%+12.17%+32.88% 6.79B
-.--%+0.14% - - 6.79B
+1.99%+1.91%+4.68%+183.54% 6.6B
Average -0.23%+0.72%+16.04%+73.08% 14.81B
Weighted average by Cap. -0.61%+1.25%+24.86%+82.48%

Financials

2024 2025
Net sales 2.44B 361M 314M 292M 268M 507M 34.49B 515M 3.45B 1.35B 17.17B 1.36B 1.33B 57.58B 2.14B 316M 275M 256M 235M 444M 30.18B 450M 3.02B 1.18B 15.02B 1.19B 1.16B 50.38B
Net income 233M 34.46M 29.95M 27.88M 25.6M 48.34M 3.29B 49.09M 329M 129M 1.64B 129M 127M 5.49B 377M 55.8M 48.51M 45.15M 41.45M 78.28M 5.33B 79.49M 532M 209M 2.65B 210M 205M 8.89B
Net Debt -509M -75.31M -65.46M -60.93M -55.94M -106M -7.19B -107M -718M -282M -3.58B -283M -277M -12B -838M -124M -108M -100M -92.17M -174M -11.84B -177M -1.18B -464M -5.9B -466M -456M -19.77B
Logo Harbin Gloria Pharmaceuticals Co., Ltd
HARBIN GLORIA PHARMACEUTICALS Co Ltd is a China-based company principally engaged in the research, development, production and sale of pharmaceuticals. The Company operates its businesses through three segments. The Traditional Chinese Medicine segment's main product is Annao Pills and Tablets. The Chemical Pharmaceuticals segment's products include cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamins, electrolytes, analgesics, anti-infectives, anti-tumor drugs and others. The Others segment engages in pharmaceutical research and development, clinical services and others. The Company distributes its products within the domestic market and to overseas markets.
Employees
2,350
Date Price Change Volume
31/07/26 CN¥2.850 +0.35% 45,266,959
30/07/26 CN¥2.840 -1.39% 71,847,619
29/07/26 CN¥2.880 -.--% 64,279,275
28/07/26 CN¥2.880 -0.69% 65,853,700
27/07/26 CN¥2.900 +5.07% 75,486,400

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002437 Stock